ORSEGIVI

Serial Number 99236964
641

Registration Progress

Application Filed
Jun 16, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Jan 28, 2026 40 days

Trademark Image

ORSEGIVI

Basic Information

Serial Number
99236964
Filing Date
June 16, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Oct 28, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Janina Gorbach

USPTO Deadlines

Next Deadline
40 days remaining
Non-Final Action E-Mailed
Due Date
January 28, 2026
Extension Available
Until April 28, 2026

Application History

7 events
Date Code Type Description Documents
Oct 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 28, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 28, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 22, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 16, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, cachexia, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use

Classification

International Classes
005